Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap

Introduction We investigated risk of coronary heart disease and heart failure in phenotypes of obstructive airway disease. Methods Among 91 692 participants in the Copenhagen General Population Study, 42 058 individuals were classified with no respiratory disease, and 11 988 individuals had different phenotypes of obstructive airways disease: asthma with early onset or late-onset, chronic obstructive pulmonary disease (COPD) with forced expiratory volume in one second (FEV1) above or below 50% of predicted value (%p) or asthma-COPD overlap (ACO). Results During a mean follow-up of 5.7 years we registered 3584 admissions for coronary heart disease and 1590 admissions for heart failure. Multivariable Cox regression analyses of time to first admission were used with a two-sided p value of 0.05 as significance level. Compared with no respiratory disease the highest risks of coronary heart disease and heart failure were observed in ACO with late-onset asthma and FEV1 <50% p, HR=2.2 (95% CI 1.6 to 3.0), and HR=2.9 (95% CI 2.0 to 4.3), respectively. In COPD with FEV1 above 50% p the HRs were 1.3 (95% CI 1.2 to 1.5) for coronary heart disease and 1.9 (95% CI 1.6 to 2.3) for heart failure. Asthma associated with increased risks of coronary heart disease and heart failure, however, in asthma without allergy the HR was 1.1 (95% CI 0.7 to 1.6) for coronary heart disease while individuals with allergy had an HR of 1.4 (95% CI 1.1 to 1.6). Conclusions Risks of coronary heart disease and heart failure were increased in asthma, COPD and ACO. In asthma, the risk of coronary heart disease depended on presence of allergy. We suggest that cardiovascular risk factors should be assessed systematically in individuals with obstructive airway disease with the potential to facilitate targeted treatments.

[1]  J. Hallas,et al.  Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD , 2019, Respirology.

[2]  Xu-fang Xie,et al.  Relationship of atopic dermatitis with stroke and myocardial infarction , 2018, Medicine.

[3]  Cheng-Li Lin,et al.  Association of asthma–chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study , 2017, BMJ Open.

[4]  Chin-Chou Wang,et al.  Impact of overweight and obesity on acute exacerbations of COPD – subgroup analysis of the Taiwan Obstructive Lung Disease cohort , 2017, International journal of chronic obstructive pulmonary disease.

[5]  W. Tan,et al.  Association of asthma with coronary heart disease: A meta analysis of 11 trials , 2017, PloS one.

[6]  M. Miravitlles.  Diagnosis of asthma–COPD overlap: the five commandments , 2017, European Respiratory Journal.

[7]  D. Sin,et al.  Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care. , 2016, American journal of respiratory and critical care medicine.

[8]  H. Bøtker,et al.  Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study , 2016, BMJ Open.

[9]  V. Roger,et al.  Asthma Status and Risk of Incident Myocardial Infarction: A Population-Based Case-Control Study. , 2016, The journal of allergy and clinical immunology. In practice.

[10]  P. Peppard,et al.  Late‐Onset Asthma Predicts Cardiovascular Disease Events: The Wisconsin Sleep Cohort , 2016, Journal of the American Heart Association.

[11]  J. Vestbo,et al.  Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. , 2016, The Lancet. Respiratory medicine.

[12]  Lingfei Kong,et al.  Prevalence of Comorbidities in Asthma and Nonasthma Patients , 2016, Medicine.

[13]  F. Martinez,et al.  Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial , 2016, The Lancet.

[14]  J. Soriano,et al.  Comorbidome, Pattern, and Impact of Asthma-COPD Overlap Syndrome in Real Life. , 2016, Chest.

[15]  Dirkje S Postma,et al.  The Asthma-COPD Overlap Syndrome. , 2015, The New England journal of medicine.

[16]  M. Sadatsafavi,et al.  Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. , 2015, The Lancet. Respiratory medicine.

[17]  Finn Gyntelberg,et al.  Ranking of psychosocial and traditional risk factors by importance for coronary heart disease: the Copenhagen City Heart Study. , 2015, European heart journal.

[18]  Claudia E Korcarz,et al.  Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis. , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Edwin J R van Beek,et al.  The clinical and genetic features of COPD-asthma overlap syndrome , 2014, European Respiratory Journal.

[20]  N. Chavannes,et al.  Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study , 2014, PloS one.

[21]  D. Mannino,et al.  Chronic Obstructive Pulmonary Disease and Asthma–Patient Characteristics and Health Impairment , 2013, COPD.

[22]  A. Agustí,et al.  Cardiovascular comorbidity in COPD: systematic literature review. , 2013, Chest.

[23]  E. Antón,et al.  Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). , 2013, Respiratory medicine.

[24]  B. Nordestgaard,et al.  New Danish reference values for spirometry , 2013, The clinical respiratory journal.

[25]  C. Iribarren,et al.  Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts. , 2012, American journal of epidemiology.

[26]  Morten Dahl,et al.  Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. , 2012, American journal of respiratory and critical care medicine.

[27]  L. Chambless,et al.  Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study , 2012, European journal of heart failure.

[28]  J. Hurst,et al.  Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art , 2011, Expert review of respiratory medicine.

[29]  Elsebeth Lynge,et al.  The Danish National Patient Register , 2011, Scandinavian journal of public health.

[30]  L. Boulet,et al.  Asthma-related comorbidities , 2011, Expert review of respiratory medicine.

[31]  J. Vestbo,et al.  Cardiovascular Morbidity in COPD: A Study of the General Population , 2011, COPD.

[32]  Y. Chae,et al.  Relation between common allergic symptoms and coronary heart disease among NHANES III participants. , 2010, The American journal of cardiology.

[33]  M. Kivimäki,et al.  Self-report as an indicator of incident disease. , 2010, Annals of epidemiology.

[34]  Ulrich Bothner,et al.  Chronic obstructive pulmonary disease and the risk of cardiovascular diseases , 2010, European Journal of Epidemiology.

[35]  M. Triggiani,et al.  Allergy and the cardiovascular system , 2008, Clinical and experimental immunology.

[36]  L. Køber,et al.  Accuracy of a heart failure diagnosis in administrative registers , 2008, European journal of heart failure.

[37]  Stephen J. Galli,et al.  The development of allergic inflammation , 2008, Nature.

[38]  Fernando Holguin,et al.  Relation of adult-onset asthma to coronary heart disease and stroke. , 2008, The American journal of cardiology.

[39]  Richard Beasley,et al.  External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? , 2006, Thorax.

[40]  W. Poewe,et al.  Allergic rhinitis, asthma, and atherosclerosis in the Bruneck and ARMY studies. , 2005, Archives of internal medicine.

[41]  A. Folsom,et al.  Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study , 2005, Thorax.

[42]  D. Waters,et al.  Implications of cigarette smoking for the management of patients with acute coronary syndromes. , 2003, Progress in cardiovascular diseases.

[43]  J. Bousquet,et al.  Epidemiologic evidence for asthma and rhinitis comorbidity. , 2000, The Journal of allergy and clinical immunology.

[44]  M. Pfeffer,et al.  Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. , 2000, Circulation.

[45]  T. F. Andersen,et al.  The Danish National Hospital Register. A valuable source of data for modern health sciences. , 1999, Danish medical bulletin.

[46]  Z. Ying,et al.  Checking the Cox model with cumulative sums of martingale-based residuals , 1993 .

[47]  B Järvholm,et al.  Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. , 1993, Chest.

[48]  J. Soriano,et al.  Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort. , 2016, Chest.

[49]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[50]  K. Torén,et al.  Self-reported asthma was biased in relation to disease severity while reported year of asthma onset was accurate. , 2006, Journal of clinical epidemiology.